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Background: Reducing premature mortality is a crucial public health objective. After a long gap in the publication
of Belgian mortality statistics, this paper presents the leading causes and the regional disparities in premature
mortality in 2008–2009 and the changes since 1993.
Methods: All deaths occurring in the periods 1993–1999 and 2003–2009, in people aged 1–74 residing in Belgium
were included.
The cause of death and population data for Belgium were provided by Statistics Belgium , while data for
international comparisons were extracted from the WHO mortality database.
Age-adjusted mortality rates and Person Year of Life Lost (PYLL) were calculated. The Rate Ratios were computed
for regional and international comparisons, using the region or country with the lowest rate as reference; statistical
significance was tested assuming a Poisson distribution of the number of deaths.
Results: The burden of premature mortality is much higher in men than in women (respectively 42% and 24% of
the total number of deaths). The 2008–9 burden of premature mortality in Belgium reaches 6410 and 3440 PYLL per
100,000, respectively in males and females, ranking 4th and 3rd worst within the EU15. The disparities between Belgian
regions are substantial: for overall premature mortality, respective excess of 40% and 20% among males, 30% and 20%
among females are observed in Wallonia and Brussels as compared to Flanders. Also in cause specific mortality,
Wallonia experiences a clear disadvantage compared to Flanders. Brussels shows an intermediate level for natural
causes, but ranks differently for external causes, with less road accidents and suicide and more non-transport accidents
than in the other regions.
Age-adjusted premature mortality rates decreased by 29% among men and by 22% among women over a period of
15 years. Among men, circulatory diseases death rates decreased the fastest (−43.4%), followed by the neoplasms
(−26.6%), the other natural causes (−21.0%) and the external causes (−20.8%). The larger decrease in single cause is
observed for stomach cancer (−48.4%), road accident (−44%), genital organs (−40.4%) and lung (−34.6%) cancers. On
the opposite, liver cancer death rate increased by 16%.
Among female, the most remarkable feature is the 50.2% increase in the lung cancer death rate. For most other causes,
the decline is slightly weaker than in men.
Conclusion: Despite a steady decrease over time, international comparisons of the premature mortality burden
highlight the room for improvement in Belgium. The disadvantage in Wallonia and to some extent in Brussels suggest
the role of socio-economic factors; well- designed health policies could contribute to reduce the regional disparities.
The increase in female lung cancer mortality is worrying.
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Reducing premature deaths is a crucial goal of public
health policies [1]; premature mortality statistics are invalu-
able indicators to assist important public health functions:
the establishment of priorities, the monitoring of temporal
trends to evaluate the impact of public health actions and
the detection of geographical disparities that can highlight
problems in resources allocations or non-medical health
determinants [2,3].
Traditional age-adjusted mortality rates allow for tem-
poral or geographical comparisons of premature death
figures. However, as stated by the US Centre for Diseases
Control and Prevention (CDC) [2], death rates often fail
to tell the entire story of premature mortality: since most
deaths occur in older age-groups, mortality rates are
dominated by the underlying diseases of the elderly. An
alternative measure has been proposed [2,4,5], the
“Potential Years of Life Lost (PYLL)”, an indicator
weighting the deaths occurring at younger ages more
heavily than those occurring later. It has been largely
used as a planning tool since the 1980s.
In Belgium, previous studies analysed the cause-specific
(premature) mortality either using rates or PYLL [6-9].
The latest published studies refer to years up to 1997; after-
wards, there has been a long hiatus in the publication of
mortality data due to a reorganisation of the responsibil-
ities in processing the death certificates. For more than
12 years, Belgian mortality data were only partially avail-
able on the regional levels. Recently, causes of deaths data
have been produced again at the national level. Those are
currently (December 2013 ) available for nearly all years
previous to 2009 (except for 2000–2002). This prompted
us to analyse the recent patterns of premature mortality.
The current paper presents the 2008–9 premature mortal-
ity figures using both death rates and PYLL; the aim is to
identify the leading causes of premature death, to look at
regional disparities and to monitor the changes since 1993.
In addition the overall Belgian premature mortality level is
compared to the EU15 countries.Methods
Period and people under study
Premature mortality is defined here as death occurring
before 75 years. All deaths occurring in the periods
1993–1999 and 2003–2009 (last available years at na-
tional level in December 2013), in people aged 1 to
74 years and residing in Belgium were included. Infant
deaths are excluded from the study.
Cause of death and population data for Belgium are
provided by Statistics Belgium, Directorate in charge
of the production of vital statistics at the national level.
The causes of death are specified in deaths certificates
by a medical doctor; they are subsequently codedaccording to the ICD rules by trained staff within 2 re-
gional Health Agencies (one for Flanders and Brussels,
one for Wallonia), before being pooled at the national level
by Statistics Belgium. Regular coordination meetings be-
tween the regional and federal levels are organised in order
to guarantee consistency in the coding/registration rules.
Deaths and population data for International
comparisons: deaths and population data by sex and
5 years age groups for the EU15 countries were ex-
tracted from the WHO Mortality Database to compare
overall PYLL rates.
Classifications in use: the 9th revision of the Inter-
national Classification of Disease (ICD-9) was in use until
1997 while the ICD-10 was introduced in 1998 [10,11].
Causes of deaths were poorly coded (except for neoplasms)
in the first 2 years after the adoption of the 10th revision
(1998–1999); consequently for those 2 years only overall
and cancer mortality will be published. The transition in
ICD-classification created also jumps in the subclasses of
circulatory diseases; hence those will not be used in the
trends analysis. As suicide is often suspected being under-
reported, several correction methods have been proposed
[12-15]. We will, in addition to the registered suicide data,
calculate estimations by using Jougla’s method [13].
Grouping of the causes of death: the causes of death
are displayed according to the ICD-chapters. Chapters
with less than 200 yearly cases for Belgium are not
shown separately. Besides, single causes or group of
causes are presented for cancers, circulatory diseases
and external causes, as well as for some single causes
also relevant for health promotion (chronic liver dis-
eases, COPD). The classification used along with ICD-9
and ICD-10 is summarized in Table 1.
Indicators: age-standardised death rates (1–74 year)
are computed with the direct method [16]. Potential Years
of Life Lost (PYLL), at population level, between 1 and
74 years are computed as the summation of the remaining
years, had the deceased lived up to 75 years. Individual
age at death was used for the computation. The age ad-
justed PYLL rates per 100.000 are calculated according to
the method described by Romeder [5]. Mortality rates and
PYLL-rates used for Belgian regional or time-trends com-
parisons are age-adjusted with the 2000 Belgian popula-
tion as a standard, while for EU15 comparisons, the
European Standard population [17] is used.Comparisons and statistical analysis
– Cause specific mortality rates were compared
between the regions and between EU15 countries
with the Rate Ratios of the age-adjusted mortality
rates, using the region/country with the lowest rate
as reference (Flanders, Sweden Spain). To test for
Table 1 ICD-9 and ICD10 codes for the categories and single causes of deaths used
ICD chapter Selected single causes
or group of causes
ICD9 ICD10 Clusters of main causes






Neoplasms 140-239 C00-D48 Neoplasms
Head,neck& oesoph.Ca 140-149;161;150 C00-C14;C30-C32;C15
Stomach Ca 151 C16
Colorectal Ca 153;154.0;154.1 C18-C20
Liver Ca 155 C22
Pancreas Ca 157 C25
Lung Ca 162 C33-C34
Female Breast Ca 174 C50
Female genital org.Ca 179-184 C51-C58
Male genital org.Ca 185-187 C60-C63
CNS Ca 191-192 C70-C72
Hematol.Ca 200-208 C81-C96
Other Neoplasms
Endocrine dis 240-279 E00-E99
Mental&Neurol
Dis.
290-319; 320-389 F00-F99; G00-G99
Circulatory
diseases














External causes E800-899 V01-Y98 External causes











*Chapters with less than 200 yearly cases were not displayed.
**Miscellaneous other external causes include non-road transport accidents (train, plane, water), homicide, iatrogenic, legal interventions and war.
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variance of the age-adjusted rates using a Poisson








 2A z-test [19] was then performed as z = (ASR1-ASR2)/
SQRT (Var (ASR1) + Var(ASR2))
The 95% confidence interval of the age-adjusted rates
was also computed for the international rates.
Where ASR = Age Standardized rates; ai = age- specific
rates per 100.000 in the age-group i; ni = effectif of the
population for the age group i; wi = effectif of the
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ance of the age-standardized rates.
Beside the statistical comparison, the EU countries
were ranked by sex based on the burden of overall
premature mortality expressed in PYLL; the causes of
deaths were also ranked by region in function of their
burden expressed in PYLL.
The evolution between the 1st and 4th period is
expressed as a relative rate difference (Rate 4th –Rate
1st)/rate 1st; the statistical significance was tested
with a z-test calculated the same way as for regional
comparisons.
All analyses were performed using SAS 9.3 statistical
software.
Results
Overall premature mortality and share of the main
categories of causes of death in 2008–9
Among the 207.571 deaths that occurred in Belgium in
2008–2009, we focused here on the 69.571 deaths
(33.5% of the total) that were non-infant premature
deaths (1–74 yr); the remaining deaths were infant
deaths (0.4% of all deaths), and deaths occurring in
people aged 75 and over (66.1%). While the total num-
ber of deaths is similar in both sexes, the fraction of
those deaths that occurs prematurely (as defined here
before 75) is much higher in men than in women, repre-
senting 42% and 24% of the total deaths respectively.
Belgium ranks 4th worst for premature mortality in
males and 3rd worst for females in the EU15 (ranked
on PYLL) (Table 2) with a quite similar ranking based
on rates. Compared to the countries with the lowest
rates (Sweden and Spain, respectively for men and
women) the premature mortality Rate Ratios for
Belgium are 1.31 in men and 1.40 in women.
Table 3 displays the age-adjusted death rates (1–74
years), PYLL and share by sex for the main categories of
conditions (neoplasms, circulatory diseases, all other nat-
ural causes, and external causes) in 2008–9. Male to female
ratio is nearly 2 for the overall mortality rates/PYLL, but
varies with the specific causes, ranging from 1.6 and 1.3 (as
expressed respectively in rates or in PYLL) for neoplasms
to 2.6 and 3.0 for external causes.
Neoplasms represent the first group of premature
mortality, both in men and women. The next cause
depends on the indicator selected: using mortality
rates, the mixed group of ”all other natural causes”
ranks second, followed by circulatory diseases and ex-
ternal causes, the latter representing 13.2% and 9.5%
in males and females respectively. However, when
using PYLL, external causes represent respectively
28.0% and 17.7% in males and females. This shift is
due to the fact that most external causes of death
occur in younger people.Regional differences in overall and cause-specific prema-
ture deaths
Important regional differences are observed both in over-
all and in cause-specific premature mortality (Tables 4 and
5). Flanders has the lowest overall premature deaths rates
in both sexes (409.6 per 100.000 in males and 224.4 per
100.000 in females). Overall rates in Brussels and Wallonia
are respectively 20 and 40% higher in men and 20 and
30% higher in women compared to Flanders.
In men, important regional differences are also observed
for specific causes: compared to Flanders, Wallonia experi-
ences a 20% excess in cancer death rates (rates ratio = 1.2).
Higher death rates are observed in head & neck, lung,
liver, pancreas and the miscellaneous other neoplasms,
while no regional difference was observed in stomach,
colorectal, reproductive organs, haematological and central
nervous system cancers. Circulatory diseases present an
excess of 30% in Wallonia. The highest excess of death
rates (80%) is seen for the miscellaneous group of ‘All
other natural causes’, in which the excess ranges between
70 and 110%, depending on the specific causes. The group
of external causes presents a 50% excess in Wallonia, with
60% in road as well as in non-transport accidents and 40%
for reported suicide.
Compared to Flanders, Brussels presents a 10% excess
in male cancer premature death rates (1–74 years). Only
liver cancer and “miscellaneous other cancer” show a
statistically significant excess with respect to Flanders.
Deaths from circulatory diseases and all other natural
causes are respectively 20% and 60% higher than in Flan-
ders. Among the external causes, death rates from road
accidents in Brussels represent half the Flemish rates,
while the rates for non-transport accidents is 50%
higher. Reported suicide rates are 20% lower than in
Flanders. The death rate for external events of undeter-
mined intent is much higher in Brussels than in the
other regions.
In women, excess in Brussels and Walloon’ s rates are
observed for the same natural causes of death as for
men, with a slightly smaller magnitude, except for head
& neck and lung cancer death rates with a 40% excess
over Flanders rates in women (against 20% in men).
There is no regional difference in the premature breast,
gynaecological, colorectal, haematological and CNS can-
cer death rate. Among external causes, suicide rate in
women is 18% higher in Wallonia than in Flanders
(versus 40% higher in men).
Reported and estimated suicide rates
As the categories “event of undetermined intent”
(Y10-Y34) and ill-defined and unknown conditions
(R96-R99) potentially include suicides, Jougla’s correc-
tion [13] has been applied to the reported suicide rates;
estimated male suicide rates (1–74 yr) respectively in
Table 2 Premature mortality (1–75 yr) in EU-15 countries, 2008–2009 Person-years of Life Lost, Rates and Ranking
Country PYLL 1-75 RANK Pyll 1-75 RATES 1-75 RANK Rates 1-75 RATIO Rates 1-75 95% CI Rates 1-75
Sex =Males
Finland 7177 1 437.6 1 1.45 [432.1; 443.0]
Portugal 6997 2 428.9 3 1.42 [425.0; 432.8]
France 6477 3 392.1 5 1.30 [390.5; 393.7]
Belgium 6211 4 396.5 4 1.31 [392.7; 400.2]
Greece 6183 5 379.6 7 1.26 [376.1; 383.1]
Denmark 6151 6 429.5 2 1.42 [424.1; 434.9]
Austria 5817 7 378.9 8 1.25 [374.8; 383.0]
Ireland 5798 8 372.1 9 1.23 [366.0; 378.3]
Germany 5751 9 388.3 6 1.29 [387.0; 389.6]
United Kingdom 5628 10 362.6 10 1.20 [361.1; 364.1]
Spain 5476 11 358.9 11 1.19 [357.2; 360.7]
Luxembourg 4862 12 330.5 12 1.09 [314.1; 347.0]
Italy 4727 13 314.2 14 1.04 [312.9; 315.6]
Netherlands 4544 14 326.0 13 1.08 [323.3; 328.7]
Sweden 4518 15 302.1 15 1.00 [298.7; 305.5]
EU15 mean 5661 . 367.8 . . [367.2; 368.4]
Sex = Females
Country PYLL 1-75 RANK Pyll 1-75 RATES 1-75 RANK Rates 1-75 RATIO Rates 1-75 95% CI Rates 1-75
Denmark 3724 1 272.0 1 1.78 [267.8; 276.2]
United Kingdom 3403 2 227.8 2 1.50 [226.7; 229.0]
Belgium 3341 3 213.9 4 1.40 [211.2; 216.5]
Ireland 3259 4 216.5 3 1.42 [211.9; 221.2]
Netherlands 3137 5 211.0 5 1.38 [208.8; 213.1]
Finland 3086 6 194.3 7 1.27 [190.8; 197.8]
Portugal 3063 7 192.9 8 1.27 [190.4; 195.3]
Germany 3008 8 201.5 6 1.32 [200.6; 202.4]
France 2953 9 177.3 12 1.16 [176.3; 178.4]
Austria 2861 10 188.9 10 1.24 [186.1; 191.7]
Sweden 2736 11 189.8 9 1.25 [187.1; 192.4]
Greece 2544 12 164.5 13 1.08 [162.3; 166.7]
Luxembourg 2514 13 182.5 11 1.20 [170.5; 194.5]
Italy 2425 14 162.8 14 1.07 [161.9; 163.7]
Spain 2422 15 152.4 15 1.00 [151.3; 153.5]
EU15 mean 2912 . 190.2 . . [189.8; 190.6]
Rates and Pyll are expressed per 100.000 Person-Years and age-standardized on European population Author's own calculation.
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per 100.000 and estimated Potential Years of Life Lost are
763, 607 and 997 per 100.000. Compared to the registered
rates (Tables 4 and 5), this represents an increase of 10%
in Flanders, 31% in Brussels and 8% in Wallonia.
In women, the estimated suicide rates (1–74 year) after
Jougla’s correction are 10.4, 10.6 and 12.3 per 100.000,
and the estimated Potential years of Life Lost are 283,263 and 316 per 100.000, respectively in Flanders,
Brussels and Wallonia. Compared to the registered rates
(Tables 4 and 5), this represents an increase of 11% in
Flanders, 34% in Brussels and 12% in Wallonia.
Ranking the top 20 causes of deaths.
Tables 6 and 7 ranks the causes of deaths according to
PYLL in each region, for 2008–2009. It is noteworthy
Table 3 Major groups of premature death (1–74 yr), Belgium 2008–2009 Age-adjusted rates and Potential Years of Life
Lost
Males Females Sex ratio
Age-adj. RATES % Age-adj.PYLL % Age-adj. RATES % Age-adj.PYLL % RATES PYLL
NEOPLASMS 175.2 37.6 1914.1 29.9 111 44.2 1444.9 42.0 1.6 1.3
OTH. NAT. CAUSES* 120 25.7 1524.9 23.8 67.5 26.9 879.2 25.6 1.8 1.7
CIRCUL. DISEASES 109.6 23.5 1176.2 18.4 49 19.5 509.6 14.8 2.2 2.3
EXTERNAL CAUSES 61.5 13.2 1795.3 28.0 23.8 9.5 605.9 17.6 2.6 3.0
TOTAL 466.3 100.0 6410.4 100.0 251.2 100.0 3439.6 100.0 1.9 1.9
*Oth. Nat. causes = all natural causes except Neoplasms and Circulatory Diseases.
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tor used: external causes (suicide, road accident, other
accidents) are ranking higher when expressed in PYLL
than in rates, while natural causes of deaths (lung can-
cer, IHD, other circulatory diseases) rank lower. For in-
stance, the suicide rate in men is much lower than the
lung cancer rates (respectively 26 and 62 per 100.000),
meaning that about 3 times as many men are dying from
lung cancer as from suicide. However, in terms of Poten-
tial Years of Life lost, suicide ranks first, due to the fact
that a great part of the suicides occur in younger people
than lung cancer deaths.
In men, at Belgian level, suicide, lung cancer, road
accident, ischaemic heart diseases and other circulatory
diseases deaths rank highest if expressed in PYLL, while
suicide and road accidents rank respectively 5th and
12th if expressed in mortality rates.
The ranking is quite similar for Flanders and Wallonia,
but differs in Brussels with respect to external causes: re-
ported suicide ranks 3rd and road accident 12th
(expressed in PYLL). However, as events of undeter-
mined intent rank much higher in Brussels, an estimated
suicide figure was computed, that ranks 2d in Brussels
(instead of 3rd) when expressed in PYLL and 6th
(instead of 9th) when expressed in rates.
In women, at Belgium level, breast cancer is the lead-
ing cause of premature death (expressed in PYLL as well
as in rates). It is followed by suicide, lung cancer, other
circulatory diseases, diseases of the digestive system.
Breast cancer is also the leading cause of death in all 3
regions; it is followed by suicide in Flanders, and by lung
cancer in Brussels and Wallonia, where suicide respect-
ively occupies the 4th and 3rd place (ranked on PYLL).
After correction, the estimated suicide figure in women
ranks 3rd in Brussels (instead of 4th) when expressed in
PYLL, and 11th (instead of 15th) if expressed in mortal-
ity rates.
Leading causes by age-group
Tables 8 and 9 details the 5 leading causes of deaths ac-
cording to age-specific mortality rates within broad age-
groups by region.Under the age of 40, suicide and accidents rank first in
all regions and in both sexes.
Lung cancers and ischemic heart diseases are the main
causes in men after 40, while suicide progressively occu-
pies a lower place.
Between 40 and 59 years, breast and lung cancer
deaths occupy the first places in women in all regions.
In women aged 60–74, the ranking and the specific
rates differ considerably between regions: breast cancer
ranks first only in Flanders (in term of mortality rates),
with slightly higher rates than in the other regions.
The other circulatory and respiratory diseases rank
first in Wallonia, with much higher mortality rates
than in Flanders. Lung cancer deaths mortality rates
are considerably higher in Brussels (where it ranks
first) and Wallonia than in Flanders.Evolution over time
Tables 10 and 11 shows the evolution of the overall and
cause specific age-standardised death rates (1–74 years)
and PYLL across 4 time periods (separated by 5 years):
1993–1994, 1998–1999, 2003–2004 and 2008–2009. For
the period 1998–1999, only overall and cancer death
rates are displayed because of a lack of reliability for the
other causes of death.
Overall premature death rates in men steadily de-
creased over the 4 time periods (Tables 10 and 11, 5th
column), reaching a 29.6% decrease between the first
(1993–4) and the 4th period (2008–2009). Mortality
rates resulting of natural causes decreased faster
(−30.7%) than for external causes (−20.8%). Within the
natural causes, circulatory diseases death rates decreased
the fastest (−43.4%), followed by the neoplasms (−26.6%)
and the other natural causes (−21.0%). The decrease in
specific cancer death rates greatly differs by organ:
change was the highest for stomach (−48.4%), followed
by genital organs (−40.4%) and lung (−34.6%) cancers.
Colorectal, head & neck and CNS cancers decrease by
more than 20%. Pancreas cancer death rates remain
stable. Finally, an increase was observed for liver cancer
(+16%).























ALL PREMATURE 466.3 6410 409.6 5491 492.9 6521 1.2** 572.2 8161 1.4**
NATURAL
CAUSES
404.7 4615 356.0 3883 436.8 5070 1.2** 493.2 5894 1.4**
ALL
NEOPLASMS
175.1 1914 164.0 1735 176.4 2069 1.1* 196.4 2210 1.2**
Head, Neck &
oesoph.Ca
16.6 219 15.6 199 17.0 220 1.1 18.6 258 1.2**
Stomach Ca 5.1 56 4.9 52 6.6 95 1.3 5.0 53 1.0
Colorectal Ca 15.6 152 15.2 143 15.8 169 1.0 16.3 163 1.1
Liver Ca 5.9 64 4.8 53 7.7 89 1.6* 7.6 80 1.6**
Pancreas Ca 9.0 92 8.3 83 10.3 105 1.2 10.0 107 1.2*
Lung Ca 61.9 630 58.2 564 56.8 625 1.0 70.1 754 1.2**
Male genital org.Ca 8.8 65 8.4 61 8.5 64 1.0 9.6 73 1.1
CNS Ca 5.9 106 6.3 111 4.9 86 0.8 5.4 104 0.9
Hematol.Ca 11.5 138 11.3 135 10.7 155 1.0 12.2 141 1.1
Other Neoplasms 34.9 391 31.0 336 38.0 462 1.2* 41.6 477 1.3**
CIRCULATORY
DISEASES
109.6 1176 99.3 1032 115.6 1257 1.2** 129.0 1434 1.3**
Isc.Heart Dis. 47.6 512 42.1 431 53.6 571 1.3** 57.0 656 1.4**
Cerebrov.dis.&HTA 20.7 209 18.4 185 21.5 239 1.2 25.3 249 1.4**
Other Circ.Dis. 41.3 455 38.8 416 40.4 447 1.0 46.7 529 1.2**
ALL OTH.NAT.
CAUSES
120.0 1525 92.8 1116 144.8 1743 1.6** 167.9 2250 1.8**
Inf.&parasit.
diseases
8.6 116 6.1 79 13.1 187 2.1** 12.6 166 2.1**
Endocrine dis 9.1 122 6.6 98 13.2 163 2.0** 13.3 160 2.0**
Mental&Neurol
Dis.
22.7 345 18.3 249 21.8 276 1.2 31.7 546 1.7**
Resp.Syst.dis. 36.3 315 29.1 237 43.8 370 1.5** 48.9 451 1.7**
Chron.Obs.Pulm.Dis. 21.5 170 16.8 122 25.7 200 1.5** 30.0 254 1.8**
Digest.Syst.Dis. 24.8 356 19.1 250 28.5 436 1.5** 34.9 534 1.8**
Chronic Liver Dis. 13.5 217 9.8 145 14.8 253 1.5** 20.2 342 2.1**
Genito-urin.Syst.
Dis
4.0 34 2.8 23 5.6 41 2.0* 5.9 55 2.1**
Sympt.&Ill-def. 10.4 158 7.4 104 13.8 189 1.9** 15.5 252 2.1**
EXTERNAL
CAUSES
61.5 1795 53.6 1608 56.2 1451 1.0 79.0 2267 1.5**
Road Accident 14.4 527 12.8 469 5.8 210 0.5** 20.1 739 1.6**
Non transp.acc.
(Poison/fall/envir.)
15.8 358 12.8 304 18.6 403 1.5** 20.8 450 1.6**
Suicide 26.2 760 23.8 717 18.5 483 0.8** 33.3 937 1.4**
Event of Undet.Intent 2.9 85 2.5 71 9.3 254 3.7** 1.9 54 0.8
Miscell.oth.Ext.causes 2.3 65 1.7 47 4.0 101 2.3** 2.9 88 1.7**
Age-adjusted rates and Potential Years of Life Lost rates per 100.000.
*ICD Chapters with fewer than 200 cases a year are not displayed.
Significance levels of the z test: '**' = p <0.01; '*' = p <0.05; 'ns' = Not significant.
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ALL PREMATURE 251.2 3440 224.4 3078 275.8 3757 1.2** 295.3 4019 1.3**
NATURAL
CAUSES
227.4 2834 203.2 2526 250.5 3137 1.2** 267.0 3317 1.3**
ALL
NEOPLASMS
111.0 1445 106.1 1398 120.0 1548 1.1** 118.1 1506 1.1**
Head, Neck &
oesoph.Ca
3.6 46 3.1 41 4.5 60 1.4 4.3 52 1.4*
Stomach Ca 2.2 30 2.0 30 2.3 38 1.1 2.4 27 1.2
Colorectal Ca 9.8 107 9.7 104 10.8 126 1.1 9.8 105 1.0
Liver Ca 2.4 23 2.1 20 3.3 37 1.6 2.7 25 1.2
Pancreas Ca 5.5 57 5.3 59 6.8 70 1.3 5.7 50 1.1
Lung Ca 19.7 248 17.0 211 23.3 287 1.4** 23.9 306 1.4**
Breast Ca 25.2 364 25.6 369 26.7 407 1.0 24.2 345 0.9
Female genital org.ca 13.4 171 13.2 174 14.3 185 1.1 13.5 162 1.0
CNS Ca 4.0 76 4.3 81 3.0 45 0.7* 3.7 76 0.9
Hematol.Ca 7.4 99 7.4 107 6.6 83 0.9 7.7 91 1.0
Other Neoplasms 17.7 223 16.4 202 18.4 209 1.1 20.2 266 1.2**
CIRCULATORY
DISEASES
49.0 510 43.8 436 53.1 560 1.2** 57.5 626 1.3**
Isc.Heart Dis. 15.1 142 13.8 124 16.7 154 1.2 17.0 171 1.2**
Cerebrov.dis.&HTA 13.9 150 12.6 132 15.2 158 1.2 15.9 180 1.3**
Other Circ.Dis. 20.0 218 17.4 180 21.1 249 1.2* 24.5 275 1.4**
ALL OTH.NAT.
CAUSES
67.5 879 53.3 691 77.4 1029 1.5** 91.5 1184 1.7**
Inf.&parasit.
diseases
5.9 86 4.2 61 8.2 134 1.9** 8.5 118 2.0**
Endocrine dis 6.0 77 4.2 65 8.3 102 2.0** 8.9 94 2.1**
Mental&Neurol
Dis.
14.5 184 12.4 148 15.2 196 1.2* 18.3 246 1.5**
Resp.Syst.dis. 16.8 173 13.7 137 18.4 178 1.3** 22.4 238 1.6**
Chron.Obs.Pulm.Dis. 9.2 89 7.1 67 9.7 97 1.4* 13.0 127 1.8**
Digest.Syst.Dis. 12.7 185 10.0 135 13.0 187 1.3* 17.7 274 1.8**
Chronic Liver Dis. 6.0 103 4.0 66 7.1 119 1.8** 9.2 167 2.3**
Genito-urin.Syst.
Dis
2.8 26 1.9 17 3.7 46 1.9* 4.2 37 2.2**
Sympt.&Ill-def. 4.6 63 3.2 41 5.4 71 1.7* 7.0 101 2.2**
EXTERNAL
CAUSES
23.8 606 21.2 552 25.3 620 1.2* 28.3 702 1.3**
Road Accident 3.9 133 3.5 123 2.2 63 0.6* 5.3 177 1.5**
Non transp.acc.
(Poison/fall/envir.)
7.1 130 5.6 98 8.2 172 1.5* 9.6 171 1.7**
Suicide 9.8 266 9.4 265 7.9 208 0.8 11.0 290 1.2*
Event of Undet.Intent 1.4 37 1.1 28 4.7 115 4.2** 1.0 28 0.9
Miscell.oth.Ext.causes 1.5 39 1.5 37 2.3 61 1.5 1.3 36 0.8
Age-adjusted rates and Potential Years of Life Lost rates per 100.000.
*ICD chapters with fewer than 200 cases a year are not displayed.
Significance levels of the z test: '**' = p <0.01; '*' = p <0.05; 'ns' = Not significant.
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1 Suicide Suicide Lung Ca Suicide
2 Lung Ca Lung Ca Isc.Heart Dis. Lung Ca
3 Road Accident Road Accident Suicide Road Accident
4 Isc.Heart Dis. Isc.Heart Dis. Other Circ.Dis. Isc.Heart Dis.








7 Digest.Syst.Dis. Digest.Syst.Dis. Resp.Syst.dis. Other Circ.Dis.
8 Mental&Neurol Dis. Mental&Neurol Dis. Mental&Neurol Dis. Resp.Syst.dis.
9 Resp.Syst.dis. Resp.Syst.dis. Event of Undet.Intent Non transp.acc.
(Poison/fall/envir.)
10 Head,neck& oesoph.Ca Head,neck& oesoph.Ca Cerebrov.dis.&HTA Head,neck& oesoph.Ca
11 Cerebrov.dis.&HTA Cerebrov.dis.&HTA Head,neck& oesoph.Ca Sympt&Ill-def.
12 Sympt&Ill-def. Colorectal Ca Road Accident Cerebrov.dis.&HTA
13 Colorectal Ca Hematol.Ca Sympt&Ill-def. Inf.&parasit.diseases
14 Hematol.Ca CNS Ca Inf.&parasit.diseases Colorectal Ca
15 Endocrine dis Sympt&Ill-def. Colorectal Ca Endocrine dis
16 Inf.&parasit.diseases Endocrine dis Endocrine dis Hematol.Ca
17 CNS Ca Pancreas Ca Hematol.Ca Pancreas Ca
18 Pancreas Ca Inf.&parasit.diseases Pancreas Ca CNS Ca
19 Event of Undet.Intent Event of Undet.Intent Miscell.oth.Ext.causes Miscell.oth.Ext.causes
20 Miscell.oth.Ext.causes Male genital org.Ca Stomach Ca Liver Ca
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44%; suicide rate slightly decreased (−11%), while the
non-transport accident increased (by 10%).
Changes over time are nearly of the same magnitude
when expressed in PYLL or in mortality rates. However,
for some conditions, the decrease in PYLL was faster
than the decrease in rates, meaning that the mortality
reduction concerned more younger than older people:
this was the case for head & neck and haematological
cancers, non-transport accident and event of undeter-
mined intent.
In women also, the overall premature death rates has
steadily declined over the 4 time periods, reaching a 22%
decrease between the 1st and the 4th period. Rates
resulting of natural or external causes declined similarly.
Within the natural causes, circulatory diseases deaths
rates decreased much faster (−44.9%) than those due to
neoplasms (−13.7%) or to the other natural causes
(−9.8%). Among deaths resulting from cancer, the
decrease was the fastest for stomach (−39.2%). Colorec-
tal, breast, haematological, gynaecological and CNS
decreased by 20-30%. Pancreas cancer death rates
remain stable. The most worrying feature is the 50.2%
increase in the lung cancer death rate. As in men, liver
cancer increased by 16%.Within the external causes, road accident decreased by
51.9%; the slight changes in suicide rate (−9%) or in
non-transport accident (by 5%) are not significant.
PYLL decreased faster than mortality rates from
breast, gynaecological, haematological, liver and lung
cancers, and non-transport accident deaths, suggesting a
more favourable evolution in young women. The reverse
was seen for stomach cancer deaths.
Discussion
Recently published data on causes of death were used to
analyse the burden, the ranking, the regional disparities
and the 15 years evolution of premature mortality in
Belgium, filling in a 12 years gap in Belgian figures. The
addition of the PYLL indicator to the classical age-
adjusted mortality rates completes the picture by weight-
ing the burden of each condition with the loss of
quantity of life. Ranking the causes of premature death
based on PYLL helps setting up priorities for policy-
makers. However, since ranks are ordinal variables, they
provide no quantitative information over the burden of
the causes; therefore, one should always consider the
value of the PYLL (or of the rates) for a specific cause,
above its ranking when setting up priorities or to make
regional comparison.
Table 7 Top 20 causes of deaths in females by region, Belgium 2008-2009








1 Breast Ca Breast Ca Breast Ca Breast Ca
2 Suicide Suicide Lung Ca Lung Ca
3 Lung Ca Lung Ca Other Circ.Dis. Suicide
4 Other Circ.Dis. Other Circ.Dis. Suicide Other Circ.Dis.
5 Digest.Syst.Dis. Female genital org.ca Mental&Neurol Dis. Digest.Syst.Dis.
6 Mental&Neurol Dis. Mental&Neurol Dis. Digest.Syst.Dis. Mental&Neurol Dis.
7 Resp.Syst.dis. Resp.Syst.dis. Female genital org.ca Resp.Syst.dis.
8 Female genital org.ca Digest.Syst.Dis. Resp.Syst.dis. Cerebrov.dis.&HTA
9 Cerebrov.dis.&HTA Cerebrov.dis.&HTA Non transp.acc.
(Poison/fall/envir.)
Road Accident
10 Isc.Heart Dis. Isc.Heart Dis. Cerebrov.dis.&HTA Non transp.acc.
(Poison/fall/envir.)
11 Road Accident Road Accident Isc.Heart Dis. Isc.Heart Dis.
12 Non transp.acc.
(Poison/fall/envir.)
Hematol.Ca Inf.&parasit.diseases Chronic Liver Dis.
13 Colorectal Ca Colorectal Ca Colorectal Ca Female genital org.ca
14 Chronic Liver Dis. Non transp.acc.
(Poison/fall/envir.)
Chronic Liver Dis. Chron.Obs.Pulm.Dis.
15 Hematol.Ca CNS Ca Event of Undet.Intent Inf.&parasit.diseases
16 Chron.Obs.Pulm.Dis. Chron.Obs.Pulm.Dis. Endocrine dis Colorectal Ca
17 Inf.&parasit.diseases Chronic Liver Dis. Chron.Obs.Pulm.Dis. Sympt&Ill-def.
18 Endocrine dis Endocrine dis Hematol.Ca Endocrine dis
19 CNS Ca Inf.&parasit.diseases Sympt&Ill-def. Hematol.Ca
20 Sympt&Ill-def. Pancreas Ca Pancreas Ca CNS Ca
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data: they do not capture morbidity nor quality of life
aspects, they rely on death certificate data of which
quality is questionable for certain age groups and certain
causes, they are coded using a classification which
evolves over time. However the advantages of vital
statistics are evident: they are routinely available, ex-
haustive, and they provide information to support health
policy. They are of particular interest for planning and
evaluating interventions aiming to reduce premature
mortality.
Quality of death registration data
Aelvoet and all [20,21] investigated the quality of the
coding of death certificates data in Belgium until 1997.
The conclusion was that the quality had appreciably im-
proved since 1993, when the responsibility of the coding
became more centralized and was assigned to the regional
Health Agencies (currently two: one is coding for Flanders
and Brussels, the second is coding for Wallonia). Caution
was however recommended for analysing long-time trends
and studying older age groups. By restricting the present
analysis to data from 1993 to 2009 and by limiting thescope to premature deaths (1–74 years), the more ques-
tionable time periods and age groups were avoided.
Despite coordination meetings between the regional
and national levels aiming to minimize the variability in
regional practices, the coding of death certificates in 2
regional Health Agencies can still result in differences in
the implementation of ICD rules. This issue will be dis-
cussed along with the interpretation of regional dispar-
ities. In 1998 a new model of death certificate was
introduced in Belgium: it is conform to the WHO model
and is suitable to be filled in by the certifying physician.
Hence, less coding errors are to be expected after the
running-in period.
The certification of the cause of death by the physician
represents a cornerstone in the production of mortality
statistics, it is thus important that it achieves a sufficient
quality level. It was not the purpose of the present study
to focus on the quality of the certification, so the quality
evaluation was limited to the calculation of the percent-
age of imprecise codes, as defined by the WHO [22].
This latter is still representing 12% in 2008–2009 (8%
for the age groups <75 years). As a consequence, efforts
should still be made to improve the quality of the deaths
Table 8 First 5 causes of deaths by age groups and region in males, Belgium 2008–2009
Age range Cause of death
Belgium
Rate Cause of death
Flanders
Rate Cause of death
Brussels
Rate Cause of death
Wallonia
Rate
1 - 39 yrs Suicide 16.4 Suicide 16.8 Suicide 10.4 Road Accident 20.8
1 - 39 yrs Road Accident 15.3 Road Accident 13.9 Non transp.acc.
(Poison/fall/envir.)
7.3 Suicide 17.9




6.7 Road Accident 6.0 Non transp.acc.
(Poison/fall/envir.)
7.0
1 - 39 yrs Mental&Neurol Dis. 4.1 Mental&Neurol Dis. 2.9 Event of Undet.Intent 5.4 Mental&Neurol Dis. 6.8
1 - 39 yrs Other Circ.Dis. 2.6 Other Circ.Dis. 2.3 Other Circ.Dis. 2.4 Other Circ.Dis. 3.2
40 - 59 yrs Lung Ca 53.2 Lung Ca 46.3 Lung Ca 49.8 Lung Ca 67.0
40 - 59 yrs Isc.Heart Dis. 44.6 Isc.Heart Dis. 35.4 Isc.Heart Dis. 47.9 Isc.Heart Dis. 60.9
40 - 59 yrs Suicide 40.9 Suicide 34.2 Digest.Syst.Dis. 41.5 Suicide 56.9
40 - 59 yrs Digest.Syst.Dis. 35.7 Other Circ.Dis. 30.4 Other Circ.Dis. 34.3 Digest.Syst.Dis. 55.5
40 - 59 yrs Other Circ.Dis. 33.9 Digest.Syst.Dis. 24.2 Suicide 27.5 Mental&Neurol Dis. 40.9
60- 74 yrs Lung Ca 286.5 Lung Ca 277.4 Lung Ca 255.8 Lung Ca 312.6
60- 74 yrs Isc.Heart Dis. 210.7 Isc.Heart Dis. 194.5 Isc.Heart Dis. 238.1 Isc.Heart Dis. 237.0
60- 74 yrs Other Circ.Dis. 184.1 Other Circ.Dis. 177.0 Resp.Syst.dis. 215.7 Resp.Syst.dis. 230.7
60- 74 yrs Resp.Syst.dis. 178.9 Resp.Syst.dis. 149.1 Other Circ.Dis. 173.7 Other Circ.Dis. 201.2
60- 74 yrs Cerebrov.dis.&HTA 94.1 Cerebrov.dis.&HTA 84.9 Digest.Syst.Dis. 96.2 Cerebrov.dis.&HTA 114.3
Age specific rate per 100.000.
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certification for the medical doctors and large dissemin-
ation of certification guidelines
Moreover, regional differences in certification might
induce differences in observed rates, For instance, the
statement that the category “events of undefined intend”
represents a higher rates in Brussels than in Flanders may
be considered to be at least partly due to regional differ-
ence in the certification rather than in coding procedures,
since the death certificates of Flanders and Brussels are
coded by the same Regional Authority.
The present study covers 2 versions of the ICD [9,10],
ICD-10 being implemented in 1998 in Belgium. Janssen
and all [23] examined the effect of coding changes
within ICD revisions. They evaluated the proportion of
discontinuity for the ICD_9 to ICD_10 change to be
lower than the former changes, namely 4.6%, and affecting
more specifically dementia, other circulatory diseases,
symptoms and ill-defined conditions, other diseases (than
those specifically studied), and falls. Specific cancers
deaths were hardly affected by those changes.
After evaluation of the data used in the present study,
it was decided not to publish the 1998–9 cause specific
results, except for neoplasms, because of instability in
coding practices. We noticed a substantial improvement
after year 2000, partly due to the use of automated cod-
ing programs. During the analysis inconsistencies were
detected in time series and in regional patterns of men-
tal and neurological diseases (data not shown). This is
due to the fact that the codes used for dementia (mainlyF01, F03 and G30), are dispersed across 2 different chap-
ters of the ICD. The choice of a specific dementia code
relies both on the diagnosis reported (by the physician
who completes the death certificate) and on the coding
rules of the Regional Agency, and has some impact on
the death rate for each of those disease groups. The spe-
cific study of dementia pattern was out of the scope of
this paper, so that it was decided to pool the chapters
about mental and neurological diseases together.The PYLL indicator
The ranking of the conditions depends on the choice of
the indicator. The PYLL indicator emphasizes causes of
death occurring at younger ages (mainly external causes)
and is generally considered more appropriate to study
the burden of premature death and to help setting up
priorities. Depending on the focus of the study, various
age limits have been used to calculate the PYLL indica-
tor [1-5,24], leading to different rankings of the causes
of death. For instance studies focusing on productivity
losses only include productive ages, mainly 20–65 years,
while in studies of premature deaths the upper cut-off
ranges from 65 to the age corresponding to life expect-
ancy, with inclusion or not of infant deaths.
In the current study the upper cut-off was set at
75 years for two reasons: reported conditions for deaths
occurring after 75 years are generally less reliable be-
cause of more frequent competing causes of death in
older people; moreover the choice of a 75 year upper-
Table 9 First 5 causes of deaths by age groups and region in females, Belgium 2008–2009
Age range Cause of death
Belgium
Rate Cause of death
Flanders
Rate Cause of death
Brussels
Rate Cause of death
Wallonia
Rate
1 - 39 yrs Suicide 5.3 Suicide 5.8 Suicide 3.7 Suicide 5.2
1 - 39 yrs Road Accident 3.6 Road Accident 3.3 Non transp.acc.
(Poison/fall/envir.)
2.4 Road Accident 4.8
1 - 39 yrs Mental&Neurol Dis. 1.8 Breast Ca 1.6 Event of Undet.Intent 2.0 Mental&Neurol Dis. 2.9
1 - 39 yrs Non transp.acc.
(Poison/fall/envir.)
1.7 Hematol.Ca 1.5 Breast Ca 1.7 Non transp.acc.
(Poison/fall/envir.)
2.4
1 - 39 yrs Breast Ca 1.6 Mental&Neurol Dis. 1.2 Mental&Neurol Dis. 1.7 Other Circ.Dis. 1.7
40 - 59 yrs Breast Ca 35.3 Breast Ca 34.7 Breast Ca 41.3 Breast Ca 34.6
40 - 59 yrs Lung Ca 25.4 Lung Ca 21.9 Lung Ca 26.1 Lung Ca 31.5
40 - 59 yrs Digest.Syst.Dis. 17.9 Female genital org.ca 16.0 Other Circ.Dis. 19.3 Digest.Syst.Dis. 28.2
40 - 59 yrs Other Circ.Dis. 16.5 Suicide 14.1 Female genital org.ca 15.9 Other Circ.Dis. 21.8
40 - 59 yrs Suicide 15.7 Other Circ.Dis. 13.2 Digest.Syst.Dis. 15.5 Suicide 19.5
60- 74 yrs Breast Ca 90.8 Breast Ca 94.0 Lung Ca 97.0 Other Circ.Dis. 106.8
60- 74 yrs Other Circ.Dis. 90.5 Other Circ.Dis. 81.9 Breast Ca 90.0 Resp.Syst.dis. 101.7
60- 74 yrs Resp.Syst.dis. 79.3 Isc.Heart Dis. 68.5 Other Circ.Dis. 90.0 Lung Ca 93.6
60- 74 yrs Lung Ca 78.2 Lung Ca 67.6 Resp.Syst.dis. 87.7 Breast Ca 85.1
60- 74 yrs Isc.Heart Dis. 72.8 Resp.Syst.dis. 66.4 Isc.Heart Dis. 81.6 Isc.Heart Dis. 78.7
Age specific rate per 100.000.
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mortality [25].
The inclusion of infant deaths is also a matter of debate.
They have been excluded from the present study, as rec-
ommended by Romeder [5], because infant mortality is
due to causes that are very specific to this age group.
Moreover, the weight given to infant deaths account for al-
most 75 years in the computed PYLL, which is probably
an overestimation of the societal weight of those deaths in
comparison of a death occurring in young adulthood. Fi-
nally, more appropriate indicators exist that specifically
address death in this particular age group.
Interpretation of findings
Compared to the other EU15 countries, overall prema-
ture deaths rates and PYLL are quite high in Belgium.
This comparison with similar countries highlights poten-
tial gains in life expectancy.
The male to female premature mortality ratio [2] is
much higher than the one observed in all age mortality
(1.6), suggesting that premature mortality contributes
more to the gender difference in life expectancy than
mortality at older ages.
Among men, the leading causes of premature deaths
ranked according to PYLL are suicide, lung cancer, road
accident, ischemic heart disease and other circulatory
disease. Among women, breast cancer still occupies the
top position, followed by suicide, lung cancer, other cir-
culatory diseases, and digestive diseases (more than half
of this latter being due to chronic liver disease). It isnoteworthy that almost all of those causes are also con-
sidered as “avoidable death”, meaning sensitive either to
the health system or to public health interventions.
There is room for improvement by further reducing
those avoidable deaths.
Regional differences
The ranking of causes of deaths is roughly the same for
Flanders and Wallonia, but differs somehow in Brussels,
where road accidents rank much lower than in the other
regions; suicide in men also occupies a lower place than
in the other regions. Regional disparities in overall and
cause specific mortality for all ages [6,9,26,27], in prema-
ture mortality [8] and in avoidable mortality [28,29] have
been documented in the past (until 1997). Since World
War II, Wallonia always experienced a clear disadvan-
tage in male mortality, mostly due to deaths related to
circulatory diseases, neoplasms, respiratory diseases,
chronic liver diseases, external causes and infectious dis-
eases. At the contrary to our finding, in the older stud-
ies, stomach cancers were higher in Flanders than in the
two other regions [7] and most of the other natural
causes didn’t show significant differences.
The present work updates, at the hand of the newly
available vital statistics, the information about the re-
gional disparities in overall and cause specific premature
mortality. An important Walloon excess in male overall
premature mortality as compared to the Flemish rates
(Rate ratio: 1.4) is still observed, for the same specific
causes as in previous studies. It is noteworthy that the
Table 10 Evolution of premature deaths in males by main causes in Belgium, across 4 time-period, 1993–2009






















ALL PREMATURE 661.9 601.6 522.0 466.3 −29.6% 8834 8020 7109 6410 −27.4% **
NATURAL CAUSES 584.2 . 456.9 404.7 −30.7% 6375 . 5111 4615 −27.6% **
ALL NEOPLASMS 238.6 216.7 190.3 175.1 −26.6% 2610 2343 2097 1914 −26.7% **
Head,Neck & oesoph.Ca 21.0 19.9 18.3 16.6 −20.8% 317 288 254 219 −30.8% **
Stomach Ca 9.8 7.8 6.3 5.1 −48.4% 97 81 72 56 −42.4% **
Colorectal Ca 20.4 19.4 16.4 15.6 −23.6% 197 188 154 152 −22.8% **
Liver Ca 5.1 5.1 5.4 5.9 16.0% 54 53 58 64 18.9% *
Pancreas Ca 9.3 9.3 8.7 9.0 −3.0% 101 93 94 92 −9.0% ns
Lung Ca 94.5 81.1 67.5 61.9 −34.6% 944 803 682 630 −33.3% **
Male genital org.Ca 14.7 13.0 10.0 8.8 −40.4% 97 86 67 65 −33.3% **
CNS Ca 7.4 6.7 5.5 5.9 −20.3% 133 115 105 106 −20.3% **
Hematol.Ca 15.6 13.9 12.7 11.5 −25.9% 214 180 154 138 −35.4% **
Other Neoplasms 40.8 40.7 39.5 34.9 −14.5% 456 457 458 391 −14.3% **
CIRCULATORY DISEASES 193.7 . 136.4 109.6 −43.4% 1893 . 1400 1176 −37.9% **
ALL OTH.NAT.CAUSES 151.9 . 130.3 120.0 −21.0% 1871 . 1614 1525 −18.5% **
Chron.Obs.Pulm.Dis. 38.1 . 25.0 21.5 −43.6% 288 . 188 170 −41.2% **
Chronic Liver Dis. 14.8 . 13.0 13.5 −8.9% 267 . 224 217 −18.7% *
Remaining Other Natural
Causes
89.1 . 81.2 76.3 −14.4% 1119 . 1056 1022 −8.7% **
EXTERNAL CAUSES 77.7 . 65.0 61.5 −20.8% 2459 . 1997 1795 −27.0% **
Road Accident 25.7 . 17.5 14.4 −44.0% 966 . 664 527 −45.5% **
Non transp.acc.(Poison/fall/
envir.)
14.4 . 14.8 15.8 9.7% 396 . 350 358 −9.6% *
Suicide 29.5 . 28.1 26.2 −11.4% 871 . 839 760 −12.7% **
Event of Undet.Intent 3.1 . 2.0 2.9 −3.6% 95 . 65 85 −11.0% ns
Miscell.oth.Ext.causes 5.0 . 2.4 2.3 −54.6% 131 . 76 65 −50.2% **
Age-adjusted rates and age-adjusted PYLL rates per 100.000.
15 years changes in rates and PYLL are displayed in bold.
$.1998-1999 figures by detailed COD not shown for lack of reliability (except for neoplasms).



















Table 11 Evolution of premature deaths in females by main causes in Belgium, across 4 time-period, 1993–2009

























ALL PREMATURE 322.2 296.9 267.2 251.2 −22.0% 4358 4064 3630 3440 −21.1% **
NATURAL CAUSES 292.1 . 243.0 227.4 −22.2% 3525 . 2988 2834 −19.6% **
ALL NEOPLASMS 128.5 121.3 111.3 111.0 −13.7% 1749 1626 1468 1445 −17.4% **
Head,Neck & oesoph.Ca 3.5 3.7 3.9 3.6 3.0% 53 53 55 46 −13.2% ns
Stomach Ca 3.6 3.1 2.3 2.2 −39.2% 38 36 27 30 −21.6% **
Colorectal Ca 13.5 12.0 10.2 9.8 −27.3% 146 131 106 107 −27.1% **
Liver Ca 2.1 2.5 2.2 2.4 16.2% 25 24 24 23 −5.8% ns
Pancreas Ca 5.7 6.3 5.4 5.5 −2.0% 57 63 50 57 0.6% ns
Lung Ca 13.1 13.9 15.9 19.7 50.2% 175 183 210 248 41.9% **
Breast Ca 33.5 31.6 26.9 25.2 −24.6% 517 482 411 364 −29.5% **
Female genital org.ca 17.3 14.9 13.7 13.4 −22.8% 232 199 172 171 −26.3% **
CNS Ca 5.6 4.7 4.0 4.0 −29.0% 103 84 70 76 −26.1% **
Hematol.Ca 9.8 8.6 8.0 7.4 −24.9% 144 116 105 99 −31.0% **
Other Neoplasms 20.9 19.9 18.8 17.7 −15.0% 260 254 237 223 −14.2% **
CIRCULATORY DISEASES 88.8 . 61.7 49.0 −44.9% 799 . 617 510 −36.2% **
ALL OTH.NAT.CAUSES 74.8 . 70.0 67.5 −9.8% 977 . 902 879 −10.0% **
Chron.Obs.Pulm.Dis. 10.2 . 9.3 9.2 −9.8% 101 . 92 89 −11.7% *
Chronic Liver Dis. 7.7 . 6.0 6.0 −22.3% 134 . 107 103 −23.0% **
Remaining Other Natural
Causes
52.3 . 47.5 46.4 −11.2% 657 . 601 601 −8.5% **
EXTERNAL CAUSES 30.1 . 24.2 23.8 −20.9% 832 . 642 606 −27.2% **
Road Accident 8.2 . 5.2 3.9 −51.9% 282 . 174 133 −52.6% **
Non transp.acc.(Poison/fall/
envir.)
6.8 . 6.5 7.1 5.1% 152 . 118 130 −14.5% ns
Suicide 10.7 . 10.1 9.8 −9.2% 287 . 280 266 −7.5% *
Event of Undet.Intent 1.4 . 0.7 1.4 0.6% 38 . 20 37 −3.3% ns
Miscell.oth.Ext.causes 2.9 . 1.7 1.5 −47.4% 73 . 51 39 −45.7% **
Age-adjusted rates and age-adjusted PYLL rates per 100.000.
15 years changes in rates and PYLL are displayed in bold.
$.1998-1999 figures by detailed COD not shown for lack of reliability (except for neoplasms).
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http://www.archpublichealth.com/content/72/1/34Wallonia-to-Flanders rate ratio for premature death is
much higher than the rate ratio for all ages mortality,
which is only 1.2 in 2009 (source = spma https://s9xjb.
wiv-isp.be/SASStoredProcess/guest?_program=/SPMA/
SP/allcaus). Again, those large regional disparities high-
light the possible room for improvement. Such regional
disparities could be explained by differences in the
socio-economic context, in health policies and to some
extent in health care practices, by environmental fac-
tors and cultural differences in health behaviour. The
socio-economic context is worse in Wallonia than in
Flanders; however, an analysis of the other factors and
particularly an evaluation of the health policies could
highlight some causes of the observed differencesthat
could be vulnerable to policy interventions.
The present study also yielded some new findings,
e.g. the former regional difference in stomach cancer
mortality (with Flanders at a disadvantage) has totally
disappeared, probably because of a change in the way
of conserving food. Beside this, a 80-100% excess was
observed in Wallonia as compared to Flanders for
many natural causes (grouped into ICD chapter,
namely mental and neurological, digestive, endocrine
diseases). This had never been described before: at
the contrary, Van Houte-Minet [6] explicitly men-
tioned that no significant regional difference was ob-
served for those specific causes during the period
1970–72. Other previous studies did not specifically
examine regional disparities for those causes.
Men in Brussels experience a premature mortality
rate intermediate between the Flemish and Walloon
rates, with a main Brussels-to-Flanders excess in the
group of “other natural causes” (+60%), then in the
circulatory diseases (+20%), and cancers (10%). While
no Brussels-to-Flanders difference is observed in the
overall rate of external causes, large differences are
observed in the specific external causes of deaths: for
evident reasons, the road accidents rate is much lower
than in the other regions. The suicide rate, even after
the Jougla’s correction, is lower in Brussels than in the
other regions and no clear explanation for this could be
found. It is noteworthy that the category of non-
transport accident (in our classification: fall, poisoning
and environmental accidents) is higher than in the
other regions, which should be further explored: there
are possibly more infrastructure problems in housing
in big towns, however suicide declared as accidental
poisoning cannot be excluded. The unexplained high
rate of events of undetermined intent in Brussels
requires caution in the interpretation of specified
external causes.
Among women, the overall Wallonia to Flanders rate
ratio for premature death is slightly less pronounced
than in men (RR = 1.3). The RR for cancer is only 1.1(10% excess); this is mainly attributable to smoking re-
lated cancers, namely head & neck and lung cancers in
which the Walloon excess reaches 40%. Rate ratios in
other causes show the same pattern as in men.
As it was the case for men, premature mortality rates
for women in Brussels are in between those of Flanders
and Wallonia, both for overall mortality and for natural
cause mortality. For external causes, a similar pattern is
observed as in men, with a lower rate of road accidents
and suicide, and a higher rate of non-transport accident.
Although coding was processed in two separate health
agencies, it is unlikely that this could explain much of the
observed regional differences. The difference in overall
mortality is anyway not related to different coding rules.
Second, as the category “symptoms and ill-defined causes”
represents a higher proportion of deaths in Wallonia
(2.6% in 2008–9) than in Flanders (1.7%) and is almost the
same as in Brussels (2.5%), any reclassification of poorly
into better-defined chapters would result in an increase of
specific death rates, that would be larger in Wallonia than
in Flanders, still accentuating the regional differences.
Finally, differences at highly aggregated levels, such as
head of ICD chapters, could hardly be due to variations in
coding practices. This was only the case for mental and
neurological diseases, a problem that was solved by pool-
ing the categories.
Only a few of single causes have been studied in detail,
namely the cancers, circulatory diseases, COPD, chronic
liver diseases and external causes. The coding of cancer
type is unlikely to be subject to regional differences; re-
gional differences in COPD and chronic liver diseases
deaths have since long been documented and explained
by life styles and working environment differences. How-
ever, a regional coding bias is not excluded for specific
circulatory diseases, so that it is preferable to only com-
pare the pooled category of circulatory diseases.
The category external causes is also prone to create
differences in coding and should be examined with cau-
tion. A clear regional bias is observed for the category
“event of undetermined intent”, which is much higher in
Brussels. Technics of correcting for not-at-random miss-
ing values could be used to further explore the apparent
differences in external deaths.
Measuring changes in the magnitude of the regional
disparities over time was out of the scope of this study,
and methodological differences between previous studies
and this one ask for more in depth research.
Evolution of the national rates over time
Among men, a substantial decrease is observed in death
rates due to road accidents, probably as a result of dras-
tic measures in the road security policy. Regarding death
related to tobacco use, a major decrease is observed in
circulatory diseases, larger than the one observed for
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gest the influence of additional factors as changes in
diet, prevention and medical treatment of hypertension.
Despite the progress observed in the last decade, road
accidents, lung cancers and circulatory diseases remain
the main causes of potential years of life lost, and policy-
makers should pursue efforts to further reduce them.
The important decrease in stomach cancer likely results
from a change in the methods of food preservation, leading
to a reduction in salt consumption. The reduction in haem-
atological and reproductive organ cancer death rates is
possibly due to improvement of chemotherapy schemes.
Suicide has hardly declined and is nowadays the main
cause of premature deaths in men at national level, when
measured in PYLL; moreover, if the correction for
underreporting is applied, suicide far exceeds all other
single causes of death in men, except in Brussels.
The slight increase of liver cancer mortality should be
further explored; this could result from a change in
reporting, but increased viral hepatitis or alcohol con-
sumption could also play a role.
The stability in non-transport accidents (fall, poison-
ing, environment) deaths should be checked, as it has
been reported that the change in ICD version impact the
way of coding for those specific causes [23].
Among women, the 15 years decrease in overall mortality
is slightly lower than in men (22% decrease in mortality
rates). Already lower mortality rates are probably harder to
improve. However, attention should be paid to the fact that
the decrease in cancer rates (−14%) is much slower than in
circulatory diseases (−45%), and slower than in men
(−27%). The 50% increase in lung cancer rates and the
stability in head & neck cancer rates are responsible for this
slower evolution. The smoking behaviour of the women
could potentially explain this evolution. As in men, the
discrepancy between the evolution in lung cancer and in
circulatory diseases mortality suggest that smoking is not
the only factor influencing the latter rate.
Conclusion
An impressive improvement in premature mortality over
the last 15 years has contributed to an increase in life
expectancy. Our study shows that mortality declined for
most causes, but the 50% increase in female lung cancer
mortality is an alarming evolution. The comparison with
EU15 countries proofs that there is room for improve-
ment. This is even more the case for the Walloon region
with distinct higher overall and cause specific mortality.
Even if the less favourable socio-economic context in
Wallonia certainly contributes to these differences, an
in-depth evaluation of health policies and health system
performance would give some insights to the roots of
the regional disparities and contribute to improve the
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